1. Identification of Patients With Glioblastoma Who May Benefit from Hypofractionated Radiotherapy.
- Author
-
Zemskova O, Yu NY, Trillenberg P, Bonsanto MM, Leppert J, and Rades D
- Subjects
- Humans, Temozolomide therapeutic use, Antineoplastic Agents, Alkylating therapeutic use, Dacarbazine therapeutic use, DNA Modification Methylases genetics, DNA Repair Enzymes genetics, DNA Methylation, Prognosis, Glioblastoma genetics, Glioblastoma radiotherapy, Glioblastoma drug therapy, Brain Neoplasms genetics, Brain Neoplasms radiotherapy, Brain Neoplasms drug therapy
- Abstract
Background/aim: Standard radiotherapy (RT) for glioblastoma lasts 6 weeks. We aimed to identify patients who would benefit from a hypofractionated approach., Patients and Methods: In 167 patients receiving standard fractionation, 10 factors were analyzed for local control (LC) and overall survival (OS). A survival score was developed and compared to a previous instrument., Results: On multivariate analysis, better LC was significantly associated with the presence of only one lesion and O
6 -methylguanine-DNA methyltransferase (MGMT) promoter methylation. Better OS was associated with one lesion, better performance status, MGMT promoter methylation, and receipt of chemotherapy. Lesion diameter ≤40 mm and upfront resection were associated with improved OS on univariate analyses. Based on assigning scores to these six factors, three groups, with 32-35, 36-44 and 45-48 points, were designed with 12-month OS-rates of 0%, 56%, and 92%, respectively. Accuracy in predicting death within 12 months and survival ≥12 months was 100% and 92%, respectively, versus 67% and 83% with the previous scoring system., Conclusion: A new survival score with higher accuracy was developed for patients with glioblastoma. Our model can be utilized to individualize RT dose-fractionation recommendations for glioblastoma., (Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF